Cancer Urology

Онкоурология

1726-97761996-1812

Publishing House ABV Press

234

10.17650/1726-9776-2011-7-3-57-59

DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. RENAL CANCER

ДИАГНОСТИКА И ЛЕЧЕНИЕ ОПУХОЛЕЙ МОЧЕПОЛОВОЙ СИСТЕМЫ. Рак почки

ВЗГЛЯД ХИМИОТЕРАПЕВТА НА «РОЛЬ АДЪЮВАНТНОЙ ГАММА-ТЕРАПИИ В ЛЕЧЕНИИ РАКА ПОЧКИ»

Носов

Д. А.

Russian Federation

nosov@mail.ru

РОНЦ им. Н.Н. Блохина РАМН, Москва

30092011

57590208201402082014

https://oncourology.abvpress.ru/oncur/article/view/234

Комментарий к статье, посвященной роли адъювантной гамма-терапии в лечении рака почки.

комментарийстатьярак почкиадъювантная гамма-терапия

1. Джабаров Ф.М., Шевченко А.Н., Розенко Л.Я. Роль адьювантной гамма-терапии в лечении рака почки. Онкоурология, 2011:16–9.

Джабаров Ф.М., Шевченко А.Н., Розенко Л.Я. Роль адьювантной гамма-терапии в лечении рака почки. Онкоурология, 2011:16–9.

2. Давыдов М.И., Матвеев В.Б. Хирургическое лечение локорегионарного рецидива рака почки после нефрэктомии. Клиническая онкоурология. М., 2003; с. 151–158.

Давыдов М.И., Матвеев В.Б. Хирургическое лечение локорегионарного рецидива рака почки после нефрэктомии. Клиническая онкоурология. М., 2003; с. 151–158.

3. Finney R. An evaluation of postoperative radiotherapy in hypernephroma treatment-α clinical trial. Cancer 1973;32:1332–40.

Finney R. An evaluation of postoperative radiotherapy in hypernephroma treatment-α clinical trial. Cancer 1973;32:1332–40.

4. Rafla S. Renal cell carcinoma: natural history and results of treatment. Cancer 1970;25:26–40.

Rafla S. Renal cell carcinoma: natural history and results of treatment. Cancer 1970;25:26–40.

5. DeKernion J.B., Ramming K.P., Smith R.B. The natural history of metastatic renal cell carcinoma: a computer analysis. J Urol 1978;120:148–52.

DeKernion J.B., Ramming K.P., Smith R.B. The natural history of metastatic renal cell carcinoma: a computer analysis. J Urol 1978;120:148–52.

6. Alter A.J., Uehling D.T., Zwiebel W.J. Computed tomography of the retroperitoneum following nephrectomy. Radiology 1979;133:663–8.

Alter A.J., Uehling D.T., Zwiebel W.J. Computed tomography of the retroperitoneum following nephrectomy. Radiology 1979;133:663–8.

7. Parienty R.A., Pradel J., Richard F. et al. Local recurrence after nephrectomy for primary renal cancer. Prog Clin Biol Res 1984;100:409.

Parienty R.A., Pradel J., Richard F. et al. Local recurrence after nephrectomy for primary renal cancer. Prog Clin Biol Res 1984;100:409.

8. Itano N.B., Blute M.L., Spotts B. et al. Outcome of isolated renal cell carcinoma fossa recurrence after nephrectomy. J Urol 2000;164:322.

Itano N.B., Blute M.L., Spotts B. et al. Outcome of isolated renal cell carcinoma fossa recurrence after nephrectomy. J Urol 2000;164:322.

9. Cho J., Kim G.E., Rha K.H. et al. Hypofractionated high-dose intensitymodulated radiotherapy (60 Gy at 2.5 Gy per fraction) for recurrent renal cell carcinoma: a case report. Korean Med Sci 2008; 23(4): 740–3.

Cho J., Kim G.E., Rha K.H. et al. Hypofractionated high-dose intensitymodulated radiotherapy (60 Gy at 2.5 Gy per fraction) for recurrent renal cell carcinoma: a case report. Korean Med Sci 2008; 23(4): 740–3.

10.

10. Gez E., Libes M., Bar-Deroma R. et al. Postoperative irradiation in localized renal cell carcinoma: the Rambam Medical Center experience. Tumori 2002;88(6):500–2.

Gez E., Libes M., Bar-Deroma R. et al. Postoperative irradiation in localized renal cell carcinoma: the Rambam Medical Center experience. Tumori 2002;88(6):500–2.

11.

11. Delahunt B., Kittelson J.M., McCredie M.R. et al. Prognostic importance of tumor size for localized conventional (clear cell) renal cell carcinoma: assessment of TNM T1 and T2 tumor categories and comparison with other prognostic parameters. Cancer 2002;94(3):658–64.

Delahunt B., Kittelson J.M., McCredie M.R. et al. Prognostic importance of tumor size for localized conventional (clear cell) renal cell carcinoma: assessment of TNM T1 and T2 tumor categories and comparison with other prognostic parameters. Cancer 2002;94(3):658–64.

12.

12. Lau W.K., Cheville J.C., Blute M.L. et al. Prognostic features of pathologic stage T1 renal cell carcinoma after radical nephrectomy. Urology 2002;59(4):532–7.

Lau W.K., Cheville J.C., Blute M.L. et al. Prognostic features of pathologic stage T1 renal cell carcinoma after radical nephrectomy. Urology 2002;59(4):532–7.

13.

13. Di Silverio F., Casale P., Colella D. et al. Independent value of tumor size and DNA ploidy for the prediction of disease progression in patients with organconfined renal cell carcinoma. Cancer 2000;88(4):835–43.

Di Silverio F., Casale P., Colella D. et al. Independent value of tumor size and DNA ploidy for the prediction of disease progression in patients with organconfined renal cell carcinoma. Cancer 2000;88(4):835–43.

14.

14. Zisman A., Pantuck A., Wieder J. et al. Risk group assessment and clinical outcome algorithm to predict the natural history of patients with surgically resected renal cell carcinoma. J Clin Oncol 2002; 20:4559–66.

Zisman A., Pantuck A., Wieder J. et al. Risk group assessment and clinical outcome algorithm to predict the natural history of patients with surgically resected renal cell carcinoma. J Clin Oncol 2002; 20:4559–66.